DCA – The Patent Pending Treatment Protocol
|February 3, 2007||Posted by Dave S. under Biology, DCA, Intelligent Design, Off Topic, Science|
In case anyone was wondering, the international patent application for DCA as a cancer cure is available for anyone to read. DCA is an inexpensive, uncontrolled chemical hailed as a potential cure for cancer that anyone can buy. This is not an endorsement or encouragement for anyone to self-medicate. It is intended solely to get the attention of established clinicians with experience in orphan drug testing.
DCA is not technically an orphan drug by definition since it treats one of the most common afflictions known to mankind (although it IS an orphan drug in Europe for a different and rare disease). It meets the orphan definition in that there’s little or no profit incentive in it.
The invention relates to the use of dichloroacetate and chemical equivalents thereof for the treatment of cancer by inducing apoptosis or reversing apoptosis-resistance in a cell Preferably, the dosage is 10-100 mg/kg Preferably, sodium dichloroacetate is used. The dichloroacetate may optionally be given in combination with a pro-apoptotic agent and/or a chemotherapeutic agent Preferably, the cancers treated are non-small cell lung cancer, glioblastoma and breast carcinoma.
There’s a lot more reading at the link. This is just the patent abstract.
Sodium dichloracetate is not a controlled substance and is available from many chemical suppliers. This link provides a list of 18 suppliers in case anyone is interested in starting a clinical test of this drug that’s already been approved for clinical testing in humans for a number of different ailments other than cancer.